Last reviewed · How we verify
NCT05219851
The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
trial testing Cancer patients underwent thoracic intensity-modulated radiotherapy in Cancer Patients in 250 participants. Status unknown.
31 March 2025
Quick facts
| Lead sponsor | Hubei Cancer Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 1 June 2022 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 October 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Cancer patients underwent thoracic intensity-modulated radiotherapy
Conditions studied
- Cancer Patients — all drugs for Cancer Patients →
Sponsor
Hubei Cancer Hospital
Who can join
Eligibility, any sex, with Cancer Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this non-interventional study is to collect data on the risk factors for acute radiation pneumonitis in patients with prior receipt of immune checkpoint inhibitors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Immune checkpoint blockade in cancer: current insights and future horizons.
Saman H, Makni-Maalej K, El-Ella DMA, Al-Tamimi MY, et al · · 2026 · PMID 41483376 · DOI 10.1007/s12672-025-04361-7
Verify or expand the search:
- PubMed search for NCT05219851
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Patients
Currently open trials in the same condition.
- NCT06864481 — Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis · recruiting
- NCT06889987 — Bilateral Ultrasound Guided Intramuscular Quadratus Lumborum Plane Block Versus Bilateral Lateral Quadratus Lumborum Pla · NA · recruiting
- NCT06348940 — Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patient · NA · active not recruiting
- NCT04802720 — A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer · NA · active not recruiting
Other Hubei Cancer Hospital trials
Trials by the same sponsor.
- NCT07188857 — Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy · not yet recruiting
- NCT06402435 — SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer · Phase 2 · recruiting
- NCT06401005 — SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) · Phase 2 · recruiting
- NCT06712524 — Effect of Different Surgical Approaches of Granulomatous Mastitis · NA · recruiting
- NCT06714084 — CNCMT：a Multi-center, Prospective, Single-arm Study · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05219851 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hubei Cancer Hospital
- Last refreshed: 15 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219851.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing